Subscribe
type here...
Subscribe

Regulatory

Russia Updates Pharma Licensing: New Timelines and Remote Inspections

Regulatory Techno -
The Russian Government has approved a new resolution updating the procedure for licensing pharmaceutical manufacturing. The document, prepared by the Ministry of Industry and...

Experts propose changes to the rules for regulating veterinary medicinal products in the EAEU

Regulatory Techno -
On February 25, a working meeting of experts was held at the Russian Union of Industrialists and Entrepreneurs (RSPP) to develop proposals for amending...
spot_imgspot_img

Recommendations on registering medical devices in EAEU adopted

Regulatory Techno -
On December 23, the Eurasian Economic Commission's Board meeting adopted the Methodological Recommendations on the content and structure of...

The EEC Collegium approved amendments to the rules for determining OTC categories of medicines

Regulatory Techno -
According to the source, the general criteria for classifying drugs as OTC have been supplemented with special criteria for individual active substances.

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Drug Development Techno -
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

FDA approves Sanofi’s Dupixent for widespread use in the United States

Regulatory Techno -
Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the...

U.S.FDA lifts ban on COVAXIN Covid-19 vaccine candidate study

Regulatory Techno -
Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, May 23th...

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

Regulatory Techno -
MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM...
Load more

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy

0
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.

Russia Updates Pharma Licensing: New Timelines and Remote Inspections

0
The Russian Government has approved a new resolution updating...

GMP-Inspections of veterinary manufacturers in July – October 2025

0
The review provides available information on the inspection of...

Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine

0
The biopharmaceutical company Nanolek, with the support of the...

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026